vs
Side-by-side financial comparison of Dine Brands Global, Inc. (DIN) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
Dine Brands Global, Inc. is the larger business by last-quarter revenue ($217.6M vs $164.7M, roughly 1.3× PTC THERAPEUTICS, INC.). Dine Brands Global, Inc. runs the higher net margin — -5.6% vs -82.0%, a 76.3% gap on every dollar of revenue. On growth, Dine Brands Global, Inc. posted the faster year-over-year revenue change (6.3% vs -22.7%). Dine Brands Global, Inc. produced more free cash flow last quarter ($-8.6M vs $-36.6M). Over the past eight quarters, Dine Brands Global, Inc.'s revenue compounded faster (2.7% CAGR vs -11.5%).
Dine Brands Global Inc. is a publicly traded food and beverage company based in Pasadena, California. Founded in 1958 as IHOP, it operates franchised and corporate owned full-service restaurants including three restaurant concepts, Applebee's Neighborhood Grill & Bar, International House of Pancakes (IHOP), and Fuzzy's Taco Shop.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
DIN vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $217.6M | $164.7M |
| Net Profit | $-12.2M | $-135.0M |
| Gross Margin | 42.4% | — |
| Operating Margin | -7.6% | -43.3% |
| Net Margin | -5.6% | -82.0% |
| Revenue YoY | 6.3% | -22.7% |
| Net Profit YoY | -336.1% | -104.8% |
| EPS (diluted) | $-0.79 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $217.6M | $164.7M | ||
| Q3 25 | $216.2M | $211.0M | ||
| Q2 25 | $230.8M | $178.9M | ||
| Q1 25 | $214.8M | $1.2B | ||
| Q4 24 | $204.8M | $213.2M | ||
| Q3 24 | $195.0M | $196.8M | ||
| Q2 24 | $206.3M | $186.7M | ||
| Q1 24 | $206.2M | $210.1M |
| Q4 25 | $-12.2M | $-135.0M | ||
| Q3 25 | $7.3M | $15.9M | ||
| Q2 25 | $13.8M | $-64.8M | ||
| Q1 25 | $8.2M | $866.6M | ||
| Q4 24 | $5.2M | $-65.9M | ||
| Q3 24 | $19.1M | $-106.7M | ||
| Q2 24 | $23.2M | $-99.2M | ||
| Q1 24 | $17.5M | $-91.6M |
| Q4 25 | 42.4% | — | ||
| Q3 25 | 39.1% | — | ||
| Q2 25 | 40.0% | — | ||
| Q1 25 | 42.0% | — | ||
| Q4 24 | 41.7% | — | ||
| Q3 24 | 47.8% | — | ||
| Q2 24 | 48.1% | — | ||
| Q1 24 | 47.2% | — |
| Q4 25 | -7.6% | -43.3% | ||
| Q3 25 | 4.7% | 1.4% | ||
| Q2 25 | 8.2% | -19.5% | ||
| Q1 25 | 6.0% | 82.5% | ||
| Q4 24 | 3.8% | -76.2% | ||
| Q3 24 | 13.6% | -27.7% | ||
| Q2 24 | 15.1% | -21.5% | ||
| Q1 24 | 11.7% | -21.6% |
| Q4 25 | -5.6% | -82.0% | ||
| Q3 25 | 3.4% | 7.5% | ||
| Q2 25 | 6.0% | -36.3% | ||
| Q1 25 | 3.8% | 73.7% | ||
| Q4 24 | 2.5% | -30.9% | ||
| Q3 24 | 9.8% | -54.2% | ||
| Q2 24 | 11.2% | -53.1% | ||
| Q1 24 | 8.5% | -43.6% |
| Q4 25 | $-0.79 | $-1.63 | ||
| Q3 25 | $0.48 | $0.20 | ||
| Q2 25 | $0.89 | $-0.83 | ||
| Q1 25 | $0.53 | $10.04 | ||
| Q4 24 | $0.35 | $-0.85 | ||
| Q3 24 | $1.24 | $-1.39 | ||
| Q2 24 | $1.50 | $-1.29 | ||
| Q1 24 | $1.13 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.2M | $1.9B |
| Total DebtLower is stronger | $1.2B | — |
| Stockholders' EquityBook value | $-273.9M | $-205.3M |
| Total Assets | $1.7B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.2M | $1.9B | ||
| Q3 25 | $167.9M | $1.7B | ||
| Q2 25 | $194.2M | $2.0B | ||
| Q1 25 | $186.5M | $2.0B | ||
| Q4 24 | $186.7M | $1.1B | ||
| Q3 24 | $169.6M | $1.0B | ||
| Q2 24 | $153.5M | $1.1B | ||
| Q1 24 | $145.0M | $884.8M |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | — |
| Q4 25 | $-273.9M | $-205.3M | ||
| Q3 25 | $-231.9M | $-155.8M | ||
| Q2 25 | $-212.5M | $-206.5M | ||
| Q1 25 | $-215.7M | $-185.8M | ||
| Q4 24 | $-216.0M | $-1.1B | ||
| Q3 24 | $-216.7M | $-1.1B | ||
| Q2 24 | $-231.7M | $-980.2M | ||
| Q1 24 | $-244.8M | $-893.9M |
| Q4 25 | $1.7B | $2.9B | ||
| Q3 25 | $1.8B | $2.6B | ||
| Q2 25 | $1.8B | $2.6B | ||
| Q1 25 | $1.8B | $2.7B | ||
| Q4 24 | $1.8B | $1.7B | ||
| Q3 24 | $1.7B | $1.8B | ||
| Q2 24 | $1.7B | $1.9B | ||
| Q1 24 | $1.7B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.7M | $-34.3M |
| Free Cash FlowOCF − Capex | $-8.6M | $-36.6M |
| FCF MarginFCF / Revenue | -3.9% | -22.3% |
| Capex IntensityCapex / Revenue | 6.6% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $53.4M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.7M | $-34.3M | ||
| Q3 25 | $30.2M | $-66.3M | ||
| Q2 25 | $37.0M | $-58.3M | ||
| Q1 25 | $16.1M | $870.1M | ||
| Q4 24 | $30.5M | $-30.0M | ||
| Q3 24 | $25.5M | $-77.0M | ||
| Q2 24 | $21.6M | $-71.5M | ||
| Q1 24 | $30.6M | $70.8M |
| Q4 25 | $-8.6M | $-36.6M | ||
| Q3 25 | $18.1M | $-69.7M | ||
| Q2 25 | $31.0M | $-59.6M | ||
| Q1 25 | $12.8M | $868.4M | ||
| Q4 24 | $26.7M | $-33.8M | ||
| Q3 24 | $22.0M | $-77.5M | ||
| Q2 24 | $18.2M | $-78.8M | ||
| Q1 24 | $27.2M | $61.2M |
| Q4 25 | -3.9% | -22.3% | ||
| Q3 25 | 8.4% | -33.1% | ||
| Q2 25 | 13.4% | -33.3% | ||
| Q1 25 | 6.0% | 73.8% | ||
| Q4 24 | 13.0% | -15.8% | ||
| Q3 24 | 11.3% | -39.4% | ||
| Q2 24 | 8.8% | -42.2% | ||
| Q1 24 | 13.2% | 29.1% |
| Q4 25 | 6.6% | 1.4% | ||
| Q3 25 | 5.6% | 1.6% | ||
| Q2 25 | 2.6% | 0.7% | ||
| Q1 25 | 1.5% | 0.1% | ||
| Q4 24 | 1.9% | 1.8% | ||
| Q3 24 | 1.8% | 0.3% | ||
| Q2 24 | 1.7% | 4.0% | ||
| Q1 24 | 1.6% | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | 4.12× | -4.17× | ||
| Q2 25 | 2.68× | — | ||
| Q1 25 | 1.97× | 1.00× | ||
| Q4 24 | 5.88× | — | ||
| Q3 24 | 1.34× | — | ||
| Q2 24 | 0.93× | — | ||
| Q1 24 | 1.75× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DIN
| Franchisor | $163.2M | 75% |
| Food And Beverage | $27.3M | 13% |
| Proprietary Product Sales And Other | $17.0M | 8% |
| Other | $8.1M | 4% |
| Franchise And Development Fees | $2.0M | 1% |
PTCT
Segment breakdown not available.
